MultiCell Technologies, Inc.  
MultiCell Technologies, Inc., is a leading provider of liver cell-based products for drug discovery and therapeutic applications. The Company specializes in innovative cell immortalization technologies that lead to the reproducible creation of highly functional cell lines.
  [Detailed Profile] - Country: Usa - State/Region: Rhode Island - City: Warwick

Kaleidos Pharma, Inc.
Kaleidos Pharma is developing a family of naturally occurring cytokines, including its lead product, TGF alpha, for GI mucositis and for therapy of Parkinson's disease.
  [Detailed Profile] - Country: Usa - State/Region: Washington - City: Seattle

Aastrom Biosciences, Inc. (Nasdaq : ASTM)
Develops proprietary patient-specific cell therapeutics for stem cell tissue repair, and the treatment of cancer and infectious disease.
  [Detailed Profile] - Country: Usa - State/Region: Michigan - City: Ann Arbor

Advanced Cell Technology, Inc.
Our focus is on the production of young cells for the treatment of cell degenerative disease.
  [Detailed Profile] - Country: Usa - State/Region: Massachusetts - City: Worcester

AllCells, LLC.
AllCells Limited Liability Company (LLC) is a biotechnology company dedicating to provide human cells and total RNA for scientific research in vitro only. Its products are not for clinical use in human.
  [Detailed Profile] - Country: USA - State/Region: California - City: Berkeley

Anthrogenesis Corporation
Anthrogenesis Corporation, provides a consistent, high-quality supply of Placental Stem Cells, Cell Culture Media and Growth Factors, as well as a variety of Umbilical Cord Blood, Human Bone Marrow and Peripheral Blood derived cell fractions as reagents to research laboratories world-wide.
  [Detailed Profile] - Country: Usa - State/Region: New Jersey - City: Cedar Knolls

AssureImmune LLC
AssureImmune - a science based cell preservation leader - provides its clients with private adult stem cell collection and preservation medical services worldwide. The company specializes in collecting, testing, and banking an individual's own healthy adult stem cells from the peripheral blood of adults and from the cord blood of healthy new born infants.
  [Detailed Profile] - Country: USA - State/Region: Florida - City: Boca Raton

Athersys
Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases. In addition, the Company has established multiple programs in the area of regenerative medicine, applying a powerful and proprietary adult stem cell technology and a complementary blend of other technologies.
  [Detailed Profile] - Country: USA - State/Region: Ohio - City: Cleveland

BabyTooth Technologies, Inc.
Tooth stem cell preservation.
  [Detailed Profile] - Country: USA

BioE Corporation
BioE is a biomedical company whose mission is to commercialize human umbilical cord blood stem cells and the associated tools and technologies needed to develop life-enhancing therapeutics and pharmaceuticals via high-quality cellular research and drug discovery.
  [Detailed Profile] - Country: USA - State/Region: Minnesota - City: St. Paul

BrainStorm Cell Therapeutics Inc. (OTC BB : BCLI)
BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease), and Spinal Cord Injury.
  [Detailed Profile] - Country: USA - State/Region: New York - City: New York

CyThera Inc.
CyThera is a biotechnology company involved in research and development of cell replacement therapeutic products.
  [Detailed Profile] - Country: Usa - State/Region: California - City: San Diego

EndGenitor Technologies, Inc.
EndGenitor Technologies, Inc.’s strategy is to rapidly commercialize adult stem cell products for sale to researchers in industry and academia. As it grows its market presence and diversifies its product lines, EndGenitor expects to launch proprietary novel stem cell therapeutics for the treatment of debilitating chronic degenerative diseases. The company is solely focusing on commercializing cell products from adult tissues that are free from any ethical controversy.
  [Detailed Profile] - Country: USA - State/Region: Indiana - City: Indianapolis

ENDOVASC Inc. (OTC bb : EVSC)
Endovasc’s licenses and patents describe technological advancements related to liposomes, stent coatings, and biodegradable/resorbable prostheses (stents) for the treatment of vascular dysfunction and heart disease. It also holds licenses and patents for the treatment of vascular dysfunction related to heart disease.
  [Detailed Profile] - Country: Usa - State/Region: Texas - City: Montgomery

Geron Corporation (Nasdaq : GERN)
Geron is focused on developing and commercializing therapeutic and diagnostic products for cancer based on our telomerase technology, and cell-based therapeutics using our human embryonic stem cell technology.
  [Detailed Profile] - Country: Usa - State/Region: California

GlobalStem, Inc.
Founded in March 2006, GlobalStem boasts a highly experienced, well-trained staff of stem cell experts. We are focused on creating standardized stem cell tools and providing contract services and technical support. Our products and services are tailored for the basic, applied, and clinical research communities. Located in Rockville, Maryland, close to Washington, DC, we are in a fast-paced, stimulating environment populated by world-class research institutions and companies.
  [Detailed Profile] - Country: USA - State/Region: Maryland - City: Rockville

Glycosan BioSystems, Inc.
The company develops (stem) cell culture technologies.
  [Detailed Profile] - Country: USA - State/Region: Utah - City: Salt Lake City

HemaCare Corporation (OTC BB : HEMA)
HemaCare collects, processes and distributes human blood products to hospitals and research-related organizations. We operate donor centers and mobile donor vehicles to collect transfusable blood products from donors, and offer human-derived blood products to health research organizations. HemaCare also provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments, to patients and in connection with clinical trials.
  [Detailed Profile] - Country: USA - State/Region: California - City: Van Nuys

Ixion Biotechnology
Dedicated to discovering and developing breakthrough cell-based therapies for metabolic disorders including primary hyperoxaluria, kidney stones, and other oxalate-related conditions, and insulin-dependent diabetes.
  [Detailed Profile] - Country: Usa - State/Region: Florida - City: Alachua

MacroPore Biosurgery
MacroPore Biosurgery is actively developing treatments for patients using regenerative cell technology. Our approach is unique in that we use adipose (fat) tissue as the source of regenerative cells. Regenerative cells from adipose tissue are of three primary kinds: adult stem cells, endothelial progenitor cells and growth factor producing cells. These cells have demonstrated in preclinical research that they have the ability to repair injured tissues.
  [Detailed Profile] - Country: Usa - State/Region: California - City: San Diego

MediStem Laboratories, Inc.
Dedicated to the advancement of adult stem cells for the treatment of human diseases.
  [Detailed Profile] - Country: USA - State/Region: Arizona - City: Tempe

Medra, Inc.
Human Fetal Stem Cell Therapy is a medical treatment whereby human Fetal Stem Cells (“mother” cells of the body) are transplanted into a patient. These cellular building blocks are usually administered intravenously (Fetal pluripotent hematopoietic stem cells) and subcutaneously (Fetal neuronal stem cells). It is a painless procedure, which takes place in approximately one hour, with no negative side effects.
  [Detailed Profile] - Country: Usa - State/Region: California - City: Malibu

Nephros Therapeutics, Inc.
Design, develop, and commercialize human cell systems to replace critical functions required for rapid and complete patient recovery in complex disease states. Nephros has developed and patented proprietary technologies to isolate, and ex vivo expand, the kidney-derived stem cells for therapeutic use to serve major unmet medical needs
  [Detailed Profile] - Country: Usa - State/Region: Rhode Island - City: Lincoln

NeuroGeneration
NeuroGeneration develops stem cell therapy products that will have a major impact on the treatment of neurological diseases, including Parkinson’s Disease, Alzheimer’s Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
  [Detailed Profile] - Country: USA - State/Region: California - City: Los Angeles

Neuronyx, Inc.
Neuronyx, Inc. is a development-stage biopharmaceutical company located in Malvern, Pennsylvania. Our mission is to discover, develop and deliver new medicines by leveraging the ability of adult bone marrow-derived stem cells to repair, regenerate and remodel tissue in acute and chronic disease settings.
  [Detailed Profile] - Country: Usa - State/Region: Pennsylvania - City: Malvern

Osiris Therapeutics, Inc.
Osiris Therapeutics is a clinical stage biotechnology company founded to commercialize stem cell products from a readily available and non-controversial source – adult bone marrow. These stem cells have the ability to repair different types of tissue and offer a very real opportunity to develop revolutionary new treatments for certain disease processes including immune disorders, heart attacks and arthritis.
  [Detailed Profile] - Country: Usa - State/Region: Maryland - City: Baltimore

PharmaFrontiers (OTC bb : PFTR)
PharmaFrontiers is a commercialization driven biotechnology company that develops autologous cellular therapies for the treatment of multiple sclerosis, congestive heart failure, and diabetes. The company is focused on autologous cellular therapy applications based on its proprietary stem cell and T-cell vaccination technologies.
  [Detailed Profile] - Country: Usa - State/Region: Texas - City: The Woodlands

PrimeGen Biotech LLC
PrimeGen Biotech LLC is a privately-held company developing proprietary methods to regenerate the potency of adult stem cells.
  [Detailed Profile] - Country: Usa - State/Region: California - City: Irvine

Progenitor Cell Therapy, LLC.
Progenitor Cell Therapy (PCT) is a client-based cell therapy services company that supports the development and commercialization of cellular therapies. Progenitor Cell Therapy provides cGMP-compliant cell manufacturing and consulting services that address regulatory, financial, technical, process, and quality system strategies. Services include a full spectrum of support and consulting related to process and product development, validation, due diligence evaluations, tissue collection, processing, and storage, product manufacturing, distribution and transportation.
  [Detailed Profile] - Country: USA - State/Region: New Jersey - City: Hackensack

Quark Biotech, Inc.
We have several research programs in stem cells; from basic research to understand the cellular events that lead to cell specialization to gene discovery to uncover growth factors that will help cure diseases and to systems to screen drugs and small chemicals.
  [Detailed Profile] - Country: Usa - State/Region: California - City: Fremont

ReachBio LLC
ReachBio provides specialized contract assays, contract research, and educational and consulting services to biopharmaceutical, agrichemical and other life science organizations worldwide. Our focus is on helping our clients expand their own organizations’ capabilities by efficiently harnessing our extensive knowledge and expertise in clinical and industrial stem cell and progenitor cell biology for their benefit. We operate strictly through a fee-for-service model in which the client owns all new intellectual property generated.
  [Detailed Profile] - Country: USA - State/Region: Washington - City: Seattle

Regenetech, Inc.
Regenetech uses a NASA based technology, originally discovered in space shuttle experiments, for a proprietary method of growing stem cells three-dimensionally (3D) in a simulated weightless environment. The Company's technology is utilized after harvesting adult stem cells from patient's peripheral blood to filter and proliferate (expand) therapeutic quantities before re-introducing them back into the original patient.
  [Detailed Profile] - Country: USA - State/Region: Texas - City: Houston

Saneron CCEL Therapeutics, Inc.
Saneron CCEL Therapeutics, Inc. is an entrepreneurial, biotechnology R&D startup company; focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which currently lack adequate treatment options.
  [Detailed Profile] - Country: Usa - State/Region: Florida - City: Tampa

Stem Cell Innovations ( SCI ) (OTC BB : SCLL)
Stem Cell Innovations is a publicly-traded (SCLL.OB) cell biology company. The company is well positioned to become a leader in the development of next generation drug discovery solutions including human cellular disease models and cell-based therapies. SCI's proprietary stem cell platform named PluriCells (TM) is capable of generating a broad range of differentiated human cell types.
  [Detailed Profile] - Country: USA - State/Region: Texas - City: Houston

Stem Cell Therapy International Corporation
Stem Cell Therapy International Corp. (SCTI), Tampa, FL, develops, manufactures, and distributes stem cell xeno- transplants (of animal origin) for medical treatment. SCTI is the world’s largest manufacturer of precursor stem cell xeno-transplants, which have been used to treat a wide range of conditions including: complications of diabetes, aging disease, neurological disorders, genetic diseases and immune deficiency disorders.
  [Detailed Profile] - Country: USA - State/Region: Florida - City: Tampa

StemCell Technologies, Inc.
StemCell Technologies is committed to supporting stem cell and many other areas of life science research worldwide by providing enabling research tools that are innovative, timely and of consistently high quality. StemCell's specialized media and cell separation products are available for a wide range of research applications, and are complemented by a diverse array of cytokines, antibodies, tissue culture reagents, as well as services including contract assays, proficiency testing, and training.
  [Detailed Profile] - Country: Usa

StemCells Inc.
To become the leader in stem cell based treatments of diseases characterized by damage to or degeneration of the central nervous system (CNS), liver, pancreas and other tissue.
  [Detailed Profile] - Country: Usa - State/Region: California - City: Palo Alto

STEMCO Biomedical, Inc.
STEMCO Biomedical, Inc. is a biotechnology company founded in 1999 and based in one of the world’s most prolific biotechnology regions, Research Triangle Park, North Carolina. The company was founded by world-class researchers at the Duke University Comprehensive Cancer Center and Stem Cell Transplant Program. These researchers developed STEMCO’s core technology over several years of studied research and active participation in transplanting stem cells into cancer patients.
  [Detailed Profile] - Country: Usa - State/Region: North Carolina - City: Durham

Stemedica Cell Technologies, Inc.
Applying stem cell technology to save, restore and improve lives.
  [Detailed Profile] - Country: USA - State/Region: California - City: San Diego

Stemina Biomarker Discovery, Inc.
Stemina’s innovative cell based assays arise from the strategic convergence of two groundbreaking technologies: stem cells and metabolomics. As a result, Stemina discovers and validates small molecules as biomarkers for high throughput drug screening and disease diagnostics in an all human system. Metabolomics enables the discovery of small molecules that can be used as candidate biomarkers of disease and pharmacological efficacy or toxicity.
  [Detailed Profile]

ViaCell, Inc.
ViaCell, Inc. is a cellular medicine company committed to developing the highest quality cellular treatments for cancer, genetic diseases, immune deficiencies and neurological diseases. ViaCell is engaged in the research and development of cellular therapy products that will be produced using the company's patented cell expansion technology called Selective AmplificationTM.
  [Detailed Profile] - Country: Usa - State/Region: Massachusetts - City: Cambridge

VistaGen Therapeutics, Inc.
Our lead drug candidate AV-101 targets two large CNS markets, epilepsy and neuropathic pain. Our key R&D partnership applies our clinically predictive in vitro embryonic stem cell technologies to discover and develop a new generation of drug candidates for diabetes and other Metabolic Syndrome diseases.
  [Detailed Profile] - Country: Usa - State/Region: California - City: Burlingame

Vitro Diagnostics, Inc.
The function of the human body reflects the activity of highly specialized cells derived from the development of undifferentiated embryonic cells. A primary strategic goal of the Company is to provide proliferating human cell lines to support stem cell research and other medical research applications. One current focus is human pancreatic cells that may be used in the development of cell transplantation therapy for the treatment of Type I diabetes.
  [Detailed Profile] - Country: Usa - State/Region: Colorado - City: Aurora